House Subcommittee Recommends $137.7 Million Increase For NCI
In Brief: GM awards Shared By Six Scientists; Pollard Named President of Salk Institute
NCI Names Brawly Director of Office of Special Populations
Owens Becomes President, NCCR
FDA approves Irinotecan, Days After ODAC Meeting
ODAC Recommends FDA Approval For Grain Tumor Implant
Letter: Headline Criticized On Letter About Consortium
Trending Stories
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
- After a brief government shutdown, FY26 funding bill is signed into law
NIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored









